InfuSystem Holdings, Inc. (INFU)
INFU Stock Price Chart
Explore InfuSystem Holdings, Inc. interactive price chart. Choose custom timeframes to analyze INFU price movements and trends.
INFU Company Profile
Discover essential business fundamentals and corporate details for InfuSystem Holdings, Inc. (INFU) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
27 Dec 2007
Employees
502.00
Website
https://www.infusystem.comCEO
Richard Armand DiIorio
Description
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
INFU Financial Timeline
Browse a chronological timeline of InfuSystem Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is $0.08, while revenue estimate is $36.83M.
Earnings released on 5 Aug 2025
EPS came in at $0.12 surpassing the estimated $0.03 by +300.00%, while revenue for the quarter reached $36.00M , missing expectations by -3.69%.
Earnings released on 8 May 2025
EPS came in at -$0.01 surpassing the estimated -$0.03 by +66.67%, while revenue for the quarter reached $34.72M , missing expectations by -3.74%.
Earnings released on 4 Mar 2025
EPS came in at $0.04 falling short of the estimated $0.08 by -50.00%, while revenue for the quarter reached $33.85M , beating expectations by +0.28%.
Earnings released on 7 Nov 2024
EPS came in at $0.08 surpassing the estimated $0.06 by +33.33%, while revenue for the quarter reached $35.32M , beating expectations by +1.20%.
Earnings released on 8 Aug 2024
EPS came in at $0.03 falling short of the estimated $0.04 by -18.19%, while revenue for the quarter reached $33.70M , beating expectations by +1.35%.
Earnings released on 9 May 2024
EPS came in at -$0.05 falling short of the estimated -$0.01 by -350.05%, while revenue for the quarter reached $32.00M , missing expectations by -0.02%.
Earnings released on 14 Mar 2024
EPS came in at $0.00 falling short of the estimated $0.00 by -0.60%, while revenue for the quarter reached $31.77M , beating expectations by +5.90%.
Earnings released on 7 Nov 2023
EPS came in at $0.03 surpassing the estimated $0.03 by +20.00%, while revenue for the quarter reached $31.91M , beating expectations by +6.36%.
Earnings released on 3 Aug 2023
EPS came in at $0.02 surpassing the estimated $0.00 by +500.60%, while revenue for the quarter reached $31.74M , beating expectations by +9.05%.
Earnings released on 4 May 2023
EPS came in at -$0.02 falling short of the estimated -$0.01 by -199.85%, while revenue for the quarter reached $30.37M , beating expectations by +5.31%.
Earnings released on 15 Mar 2023
EPS came in at $0.01 falling short of the estimated $0.04 by -76.92%, while revenue for the quarter reached $28.83M , missing expectations by -6.40%.
Earnings released on 8 Nov 2022
EPS came in at $0.02 surpassing the estimated $0.01 by +199.85%, while revenue for the quarter reached $27.28M , missing expectations by -2.69%.
Earnings released on 4 Aug 2022
EPS came in at -$0.01 falling short of the estimated -$0.01 by -49.93%, while revenue for the quarter reached $27.04M , missing expectations by -3.31%.
Earnings released on 5 May 2022
EPS came in at -$0.02 falling short of the estimated -$0.01 by -39.96%, while revenue for the quarter reached $26.76M , beating expectations by +3.20%.
Earnings released on 10 Feb 2022
EPS came in at $0.02 falling short of the estimated $0.07 by -71.43%, while revenue for the quarter reached $26.52M , missing expectations by -14.27%.
Earnings released on 15 Nov 2021
EPS came in at -$0.02 falling short of the estimated $0.06 by -133.33%, while revenue for the quarter reached $26.57M , missing expectations by -0.39%.
Earnings released on 12 Aug 2021
EPS came in at $0.04 falling short of the estimated $0.08 by -50.00%, while revenue for the quarter reached $24.83M , missing expectations by -6.36%.
Earnings released on 6 May 2021
EPS came in at $0.03 falling short of the estimated $0.04 by -25.00%, while revenue for the quarter reached $24.46M , missing expectations by -20.00%.
Earnings released on 17 Mar 2021
EPS came in at $0.49 surpassing the estimated $0.06 by +716.67%, while revenue for the quarter reached $24.71M .
Earnings released on 12 Nov 2020
EPS came in at $0.14 surpassing the estimated $0.04 by +300.00%, while revenue for the quarter reached $25.13M .
INFU Stock Performance
Access detailed INFU performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.